Physician profile
Melissa E Gutierrez
NPI 1215976840
$1,557.53
in general payments reported to CMS, 2019-2025
14 companies · $18.50 in 2025
The $18.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $223 · 2021: $172 · 2022: $49.19 · 2025: $18.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $257.79 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $243.47 | 2019-2020 | |
| Glaxosmithkline, LLC. | $214.59 | 2019-2025 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.34 | 2019-2020 | |
| Novo Nordisk INC | $157.25 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $122.54 | 2019 | |
| Lilly USA, LLC | $108.15 | 2019-2022 | |
| Abiomed | $103.19 | 2021 | |
| Merck Sharp & Dohme LLC | $51.22 | 2019-2020 | |
| Amarin Pharma, INC. | $42.06 | 2019-2020 | |
| Dermira, INC. | $24.75 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $21.08 | 2021 | |
| Gilead Sciences, INC. | $19.21 | 2020 | |
| Astellas Pharma US INC | $14.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.